RISK FACTORS FOR LUNG FUNCTION DECLINE IN SYSTEMIC SCLEROSIS INTERSTITIAL LUNG DISEASE IN A LARGE SINGLE-CENTER COHORT

Autor: Ramahi, A., Lescoat, A, Roofeh, D., Jaafar, S., Nagaraja, V., Huang, S., O'Dwyer, D., Flaherty, K., Kazerooni, E., Khanna, D.

Publikováno v: Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2022, 81, pp.750-750. ⟨10.1136/annrheumdis-2022-eular.3648⟩

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9a40bd4fecd23131e76c13a61360d943
https://hal.science/hal-03836790

Risk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohort.

Autor: Ramahi A; Division of Rheumatology and Scleroderma Program, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Lescoat A; Inserm, EHESP, Irset - Institut de Recherche en Sante, Environnement et Travail-UMRS, University of Rennes CHU Rennes, Rennes, France., Roofeh D; Division of Rheumatology and Scleroderma Program, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Nagaraja V; Division of Rheumatology and Scleroderma Program, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Namas R; Division of Rheumatology, Department of Internal Medicine, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE., Huang S; Division of Rheumatology and Scleroderma Program, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Varga J; Division of Rheumatology and Scleroderma Program, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., O'Dwyer D; Division of Pulmonary and Critical care, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Wang B; Division of Pulmonary and Critical care, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Flaherty K; Division of Pulmonary and Critical care, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Kazerooni E; Division of Cardiothoracic Radiology, Department of Radiology, University of Michigan, Ann Arbor, MI, USA., Khanna D; Division of Rheumatology and Scleroderma Program, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2023 Jul 05; Vol. 62 (7), pp. 2501-2509.

Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.

Autor: Roofeh D; Department of Internal Medicine, Division of Rheumatology, Scleroderma Program, University of Michigan, Ann Arbor, MI, USA., Brown KK; Department of Medicine, National Jewish Health, Denver, CO, USA., Kazerooni EA; Department of Internal Medicine, Division of Rheumatology, Scleroderma Program, University of Michigan, Ann Arbor, MI, USA.; Department of Radiology, Division of Cardiothoracic Radiology, University of Michigan, Ann Arbor, MI, USA., Tashkin D; Department of Medicine, Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Assassi S; Department of Internal Medicine, Division of Rheumatology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA., Martinez F; Department of Internal Medicine, Division of Pulmonary Critical Care Medicine, Weill Cornell School of Medicine, New York, NY, USA., Wells AU; Department of Internal Medicine, Division of Pulmonology, Royal Brompton Hospital and National Heart and Lung Institute, London, UK., Raghu G; Department of Internal Medicine, Division of Pulmonology, Critical Care and Sleep Medicine, University of Washington School of Medicine, Seattle, WA, USA., Denton CP; Centre for Rheumatology, Division of Medicine, University College London, London, UK., Chung L; Department of Internal Medicine, Division of Immunology and Rheumatology, Stanford University, and Palo Alto VA Health Care System, Palo Alto, CA, USA., Hoffmann-Vold AM; Department of Rheumatology, Oslo University Hospital, Oslo, Norway., Distler O; Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Johannson KA; Departments of Medicine and Community Health Sciences, Section of Respiratory Medicine, University of Calgary, Calgary, Canada., Allanore Y; Department of Rheumatology A, Cochin Hospital, APHP, Université de Paris, Paris, France., Matteson EL; Department of Internal Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN, USA., Kawano-Dourado L; HCor Research Institute, Hospital do Coração, São Paulo, Brazil.; Pulmonary Division, Heart Institute (InCor), University of Sao Paulo Medical School, São Paulo, Brazil.; INSERM 1152, University of Paris, Paris, France., Pauling JD; Musculoskeletal Research Unit, Bristol Medical School, University of Bristol, Bristol, UK.; Department of Rheumatology, North Bristol NHS Trust, Southmead, Bristol, UK., Seibold JR; Scleroderma Research Consultants, Aiken, SC, USA., Volkmann ER; Department of Internal Medicine, Division of Rheumatology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Walsh SLF; National Heart and Lung Institute, Imperial College London, London, UK., Oddis CV; Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., White ES; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Barratt SL; Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, UK.; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Southmead, Bristol, UK., Bernstein EJ; Department of Internal Medicine, Division of Rheumatology, Columbia University School of Medicine, Vagelos College of Physicians and Surgeons, New York, NY, USA., Domsic RT; Department of Internal Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Dellaripa PF; Department of Medicine, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Conway R; Department of Internal Medicine, Division of Rheumatology, Trinity College Dublin, University of Dublin, Dublin, Ireland., Rosas I; Department of Internal Medicine, Division of Pulmonology, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA., Bhatt N; Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Hsu V; Department of Internal Medicine, Division of Rheumatology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Ingegnoli F; Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Italy., Kahaleh B; Department of Internal Medicine, Division of Rheumatology, University of Toledo Medical Center, Toledo, OH, USA., Garcha P; Department of Internal Medicine, Division of Pulmonology, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA., Gupta N; Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati, Cincinnati, OH, USA., Khanna S; Department of Internal Medicine, Division of Rheumatology, University of Cincinnati, Cincinnati, OH, USA., Korsten P; Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany., Lin C; Genentech, Inc, San Francisco, CA, USA., Mathai SC; Department of Internal Medicine, Division of Pulmonology, Critical Care and Sleep Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Strand V; Department of Internal Medicine, Division of Immunology and Rheumatology, Stanford University, Palo Alto, CA, USA., Doyle TJ; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Steen V; Department of Internal Medicine, Division of Rheumatology, Georgetown University School of Medicine, Washington, DC, USA., Zoz DF; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Ovalles-Bonilla J; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Rodriguez-Pinto I; Autoimmune Disease Unit. Deaprtment of Internal Medicine. Hospital Mutua de Terrassa, University of Barcelona, Barcelona, Spain., Shenoy PD; Department of Rheumatology, Center for Arthritis and Rheumatism Excellence, Kochi, Kerala, India., Lewandoski A; Department of Internal Medicine, Division of Rheumatology, University of Michigan-Metro Health, Grand Rapids, MI, USA., Belloli E; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA., Lescoat A; Department of Internal Medicine, Division of Rheumatology, Scleroderma Program, University of Michigan, Ann Arbor, MI, USA.; Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France.; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, Rennes, France., Nagaraja V; Department of Internal Medicine, Division of Rheumatology, Scleroderma Program, University of Michigan, Ann Arbor, MI, USA., Ye W; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA., Huang S; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA., Maher T; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Southern California, Los Angeles, CA, USA., Khanna D; Department of Internal Medicine, Division of Rheumatology, Scleroderma Program, University of Michigan, Ann Arbor, MI, USA.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2023 May 02; Vol. 62 (5), pp. 1877-1886.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Systemic Sclerosis-Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration-Approved Therapies in Clinical Practice.

Autor: Khanna D; University of Michigan, Ann Arbor., Lescoat A; University of Michigan, Ann Arbor, and University of Rennes 1, Centre Hospitalier Universitaire Rennes, INSERM, École des Hautes Études en Santé Publique, and Institut de Recherche en Santé, Environnement et Travail, Rennes, France., Roofeh D; University of Michigan, Ann Arbor., Bernstein EJ; Columbia University Irving Medical Center, New York, New York., Kazerooni EA; University of Michigan, Ann Arbor., Roth MD; University of California, Los Angeles., Martinez F; New York University and Cornell University, New York., Flaherty KR; University of Michigan, Ann Arbor., Denton CP; University College of London, London, UK.

Publikováno v: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2022 Jan; Vol. 74 (1), pp. 13-27. Date of Electronic Publication: 2021 Nov 10.